can pharmacies compound semaglutide Compounded Semaglutide/Tirzepatide: Personalized, Affordable Medical Weight Loss FDA Warns Against Compounded Semaglutide

At the 12mg dose in TRIUMPH-1: Average weight loss of 28.3% at 80 weeks within the range of bariatric surgery outcomes 45.3% of participants lost 30% or more the threshold associated with bariatric surgery in published literature 65.3% achieved BMI below 30 no longer classifiable as obese by standard criteria Extension data to 104 weeks shows 30.3% average continuing to approach surgical outcomes with longer treatment The comparison is not a simple equivalence

doi: 10.1177/25424823251388650

What is Retatrutide Peptide

Do not use if you are taking any medications (especially anti-diabetes medication) or have any medical condition

Among the GLP-1RAs, liraglutide has been approved for the treatment of obesity as well

GLP-1 medications can suppress thirst